Sabra Health Care REIT (SBRA) Expected to Announce Quarterly Earnings on Wednesday

Sabra Health Care REIT (NASDAQ:SBRA) is anticipated to announce its earnings data after the market closes on Wednesday, February 19th. Analysts expect the company to announce earnings of $0.36 per share and revenue of $178.01 million for the quarter. Investors interested in registering for the company’s conference call can do so using this link.

Sabra Health Care REIT Stock Performance

NASDAQ SBRA opened at $16.24 on Wednesday. The company has a quick ratio of 4.16, a current ratio of 4.16 and a debt-to-equity ratio of 0.90. Sabra Health Care REIT has a fifty-two week low of $13.26 and a fifty-two week high of $20.03. The business has a fifty day moving average of $17.09 and a 200-day moving average of $17.63. The stock has a market cap of $3.84 billion, a price-to-earnings ratio of 39.61, a price-to-earnings-growth ratio of 2.02 and a beta of 1.25.

Sabra Health Care REIT Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, February 28th. Investors of record on Friday, February 14th will be paid a $0.30 dividend. This represents a $1.20 annualized dividend and a yield of 7.39%. The ex-dividend date is Friday, February 14th. Sabra Health Care REIT’s payout ratio is 292.69%.

Analyst Ratings Changes

Several equities research analysts have issued reports on SBRA shares. Citizens Jmp raised shares of Sabra Health Care REIT from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, January 7th. Mizuho restated a “neutral” rating and set a $20.00 target price on shares of Sabra Health Care REIT in a research report on Thursday, December 5th. Truist Financial downgraded Sabra Health Care REIT from a “buy” rating to a “hold” rating and cut their price target for the company from $18.00 to $17.00 in a report on Friday, January 17th. Finally, JMP Securities upgraded Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $20.00 price objective on the stock in a report on Tuesday, January 7th. Three investment analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $18.86.

Sabra Health Care REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.